A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal

Condition:   Schizophrenia Interventions:   Drug: Oral Antipsychotics (OAPs);   Drug: Paliperidone Palmitate 1-Month Formulation (PP1M) Sponsor:   Janssen-Cilag Farmaceutica Ltda. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials